SEC Form 4 · accession 0001209191-17-038859
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan M Garber
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 9, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2017 | A | 2,199 | $0.00 | A | 2,199 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $125.11 | Jun 8, 2017 | M | 5,320 | A | — | Jun 7, 2027 | Common Stock | 5,320 | 5,320 | D |
Explanation of responses
- F1Restricted stock unit award that vests in four annual installments from 6/08/2017.
- F2The option vests in 16 quarterly installments from 06/08/2017.